Discontinuation report BETOPTIC S
| Report ID | 170389 |
| Drug Identification Number | 01908448 |
| Brand name | BETOPTIC S |
| Common or Proper name | BETOPTIC S 0.25% SUSP. |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BETAXOLOL |
| Strength(s) | 0.25% |
| Dosage form(s) | SUSPENSION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 10ML |
| ATC code | S01ED |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2022-11-30 |
| Actual discontinuation date | 2022-12-29 |
| Remaining supply date | 2023-07-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Betoptic S 0.25% Susp. 5mL will continue to be available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2023-01-19 | French | Compare |
| v9 | 2023-01-19 | English | Compare |
| v8 | 2022-09-29 | French | Compare |
| v7 | 2022-09-29 | English | Compare |
| v6 | 2022-09-28 | French | Compare |
| v5 | 2022-09-28 | English | Compare |
| v4 | 2022-09-28 | French | Compare |
| v3 | 2022-09-28 | English | Compare |
| v2 | 2022-09-28 | English | Compare |
| v1 | 2022-09-28 | English | Compare |
Showing 1 to 10 of 10